Potassium Monophosphate

References


Mineral that helps maintain cellular integrity and water balance, nerve transmission and energy metabolism; necessary for muscle contraction. Potassium helps to lower blood pressure, lower risk of stroke, maintain muscle balance and prevent muscle cramping. Potassium helps to reduce the amount of sodium in the body. High Blood pressure, Cardiac arrhythmia, Congestive heart failure, Premenstrual syndrome, and Stroke.

Referencesre

  1. Micromedex Healthcare Series. Englewood, CO: MICROMEDEX Inc.
  2. McKevoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  3. Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.
  4. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  5. Anon. FDA approved potassium health claim notification for potassium containing foods. FDA www.cfsan.fda.gov/~dms/hclm-k.html (Accessed 1 November 2000).
  6. Breslau NA, et al. Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial. J Urol, 1998; 160(3 Pt 1):664-8.
  7. Heller HJ, et al. Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria. Urol 1998;159(5):1451-5; discussion 1455-6.
  8. Davis BR, Oberman A, Blaufox MD, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. Am J Hypertens 1994;7:926-32.
  9. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32.
  10. Whelton PK, Buring J, Borhani NO, et al. The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase 1 of the trials of hypertension prevention (TOHP). Ann Epidemiol 1995;5:85-95.
  11. Ritsema GH, Ellers G. Potassium supplements prevent serious hypokalemia in colon cleansing. Clin Radiol 1994;49(12);874-6.
  12. Murry JJ, Healy MD. Drug-mineral interactions: a new responsibility for the hospital dietician. J Am Diet Assoc 1991;91:66-73.
  13. Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. AFP 1986;33:165-74.
  14. Robertson JI. Diuretics, potassium depletion and risk of arrhythmias. Eur Heart J 1984;5(Suppl A):25-8.
  15. Campbell IA, Elmes PC. Ethambutol and the eye: zinc and copper (letter). Lancet 1975;2:711.
  16. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989;36:239-45.
  17. Deenstra M, Haalboom JRE, Struyvenberg A. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline. Eur J Clin Invest 1988;18:162-5.
  18. Granerus AK, Jagenburg R, Svanborg A. Kaliuretic effect of L-dopa treatment in parkinsonian patients. Acta Med Scand 1977;210(4):291-7.
  19. McCarron DA, Reusser ME. Are low intakes of calcium and potassium important causes of cardiovascular disease? Am J Hypertens 2001;14:206S-212S.
  20. Food and Drug Administration Science Background: Safety of Sodium Phosphates Oral Solution. September 17, 2001. www.fda.gov/cder/drug/safety/sodiumphospate.htm. (Accessed 28 May 2003)